Introduction: Genetic mutations in KCNH2, which encodes hERG, the alpha subunit of the potassium channel responsible for the I Kr current, cause long QT syndrome (LQTS), an inherited cardiac arrhythmia disorder. Electrophysiology techniques are used to correlate genotype with molecular phenotype to determine which mutations identified in patients diagnosed with LQTS are disease causing, and which are benign. These investigations are usually done using heterologous expression in cell lines, and often, epitope fusion tags are used to enable isolation and identification of the protein of interest.
INTRODUCTION
Ion channels are essential for maintaining normal physiology. Disruption of usual channel function by genetic mutation may lead to a wide variety of conditions known as channelopathies. Examples of channelopathies can be found in every organ system. Ion channelopathies are well suited for the correlation between genotype and molecular phenotype due to the techniques available to probe the electrophysiology profile of the ion channel protein variants.
Examples of channelopathies include cystic fibrosis, 1 susceptibility to malignant hyperthermia, 2 Bartter's syndrome, 3 and hyperinsulinemic hypoglycemia. 4 In the heart, hereditary cardiac arrhythmias are often due to hereditary ion channelopathies. Conditions such as Brugada syndrome, long QT syndrome (LQTS), short QT syndrome, and catecholaminergic polymorphic ventricular tachycardia, 5 are all caused by ion channel dysfunction due to mutations in channel-coding genes or proteins that interact with cardiac channels. Molecular functional phenotyping and correlation with genotype provide invaluable insight into mechanisms of disease. This investigation will focus on the studies of molecular phenotype for LQTS.
Congenital long QT syndrome is a genetic disorder that disrupts the timing of the cardiac myocyte membrane repolarizing phase of the action potential. There are 15 genes assigned to genetic loci for LQTS. Most genotype-positive patients (>90%) with LQTS have mutations in 1 of 3 channel genes, KCNQ1 (LQT1), KCNH2 (LQT2), or SCN5A (LQT3). Although the determination of genetic susceptibility to LQTS and the diagnosis of LQTS are in the clinical realm, investigation of these proteins and the resultant mutations provide additional information on arrhythmia mechanisms. Most of the molecular investigation of LQTS has utilized heterologous cell culture expression systems (such as HEK293T, CHO, COS-7, and Xenopus oocytes). Through this method of inquiry, our understanding of normal and abnormal physiology of the heart continues to be enriched.
Functional studies of ion channel proteins using mutant cDNA expression plasmids requires careful assessment of the plasmid being used. Expression studies frequently employ epitope fusions for protein detection (immuno-epitope tags), visual confirmation of cellular transduction (fluorescent protein fusions), or affinity purification (epitopes such as FLAG-tags or His-Tags). Moreover, cloning, subcloning, and amplification of site-directed mutant cDNAs can be subject to inadvertent and spurious nucleotide variants that are not always detected.
Protein fusion moieties and inadvertent variants may affect channel protein properties in unpredictable ways. Altered channel behavior may perturb functional properties of ion conductance and gating. Furthermore, channel protein translation, folding, assembly, and stability can be affected by tags and variations. Fully understanding the consequences of such experimentally induced changes is paramount for accurate analysis of expression studies of proteins.
In this investigation, we describe 3 examples of vector constructs for expression of hERG, the protein product of KCNH2 that exhibit plasmid-specific expression variation. In one case, an N-terminal myc-tag, caused significant gating changes in the I Kr . In the second case, a PCR-introduced, double missense mutation inserted when hERG was first described (V198E [c. T593A], P202L [c. C605T]) 6, 7 did not significantly affect I Kr , but perturbed channel protein expression and membrane trafficking. In the third case, a C-terminal myc-tag affects deactivation in the I Kr current. This study highlights the impact that plasmid construct features may have on hERG functional expression, and how they may interfere with accurate analysis of intended molecular manipulations.
MATERIALS AND METHODS
Approval from the institutional review board was not needed to conduct this investigation.
Plasmid preparation
The hERG cDNA, with and without the mutations V198E/P202L were inserted into the pcDNA 3.1+ vector (Invitrogen, ThermoFisher Scientific, Waltham, MA, USA) using the BamHI and XbaI restriction enzymes (New England Bio Labs, Ipswich, MA, USA). The hERG cDNA from the start to stop codon was inserted into the vector, and included a GCCACC Kozak sequence prior to the start codon. The wild type and V198E/P202L mutant inserts for the pCDNA 3.1+ were generated from other plasmids using the Q5 PCR enzyme (New England Bio Labs) using the following primers: NT Forward: 5 ′ -TAA GCA GGA TCC GCC ACC ATG CCG GTG CGG AG-3 ′ , Reverse: 5 ′ -TAA GCA TCT AGA CTA ACT GCC CGG GTC-3 ′ .The amino-terminal myc-tagged wild type hERG construct was created by cloning the hERG insert into the pCMV tag 3a vector (Stratagene, La Jolla, CA, USA) at the BAMH1 and HINDIII sites using the Q5 enzyme and the following forward and reverse primers: 5 ′ -TAA TGG ATC CAA TGC CGG TGC GGA GG-3 ′ and 5 ′ -TCC TAA GCT TCT AAC TGC CCG GGT CCG AG-3 ′ , respectively. A 5-amino acid linker (5 ′ -Ala-Arg-Ala-Asp-Pro-3 ′ ) conjoins the myc epitope to the start codon of hERG. The N-terminal myctagged hERG construct with V198E/P202L mutations were previously obtained through a gift from Dr. Gail Robertson. 6, 7 This construct has since been removed from circulation and replaced by the authors of the characterization paper with the correct hERG cDNA. 7 The C-terminal myc-tagged construct used is the pCI-Neo construct first described in McDonald et al. 8 This construct includes a C-terminal myc tag, along with a change of the last 3 amino acids in the hERG channel. The D219V pcDNA 3.1+ construct was generated through site-directed mutagenesis of the WT-hERG pcDNA3.1+ plasmid using the Q5 enzyme and the following primers: forward 5 ′ -GAC AGC CAT GGT CAA CCA CGT G-3 ′ and reverse 5 ′ -CAC GTG GTT GAC CAT GGC TGT C-3 ′ (IDT, Coralville, IA, USA). 9 The mutated gene was inserted into the pcDNA 3.1+ vector through the BamHI and XbaI restriction sites. Sequences for all plasmids were confirmed on a nucleotide level using GeneWiz Sanger sequencing (Genewiz, NJ, USA).
Throughout this manuscript, WT hERG refers to the untagged hERG pcDNA 3.1+ plasmid, V198E/P202L hERG refers to the hERG pcDNA3.1+ construct with the V198E/P202L mutations. N-myc hERG refers to the wild-type hERG with the N-terminal myc tag. N-myc V198E/P202L hERG refers to the V198E/P202L hERG with the Nterminal myc tag. C-myc hERG refers to the pCI-Neo construct with the C-terminal myc tag . D219V hERG indicates the hERG gene carrying the D219V (c.656A>T) mutation in the pcDNA 3.1+. Figure 1 demonstrates the features of each of the 4 plasmids being compared in this investigation.
Cell maintenance and transfection
Every experiment performed was done using transient transfections in human embryonic kidney (HEK) 293T cells. Cells were cultured in RPMI media (Hyclone, GE Health Care Life Sciences, Pittsburgh, PA, USA) supplemented with 10% fetal bovine serum (Hyclone) and 10,000 IU penicillin/streptomycin (Hyclone). Cells were maintained at 37 • C in a 5% CO 2 environment. All transfections were done using Fugene 6 (Promega, Madison, WI, USA) in a 8:1 Fugene (uL) to DNA (ug) ratio.
Experiments were performed at 48 hours post-transfection unless otherwise noted. has increased protein expression relative to WT hERG (n = 4, P = 0.0182), the N-terminal myc fusion tag increased protein expression relative to WT hERG (n = 4, P = 0.0002), and the C-terminal myc fusion tag does not impact protein expression relative to WT hERG (n = 5). D: Summary data for mature/immature ratio (155kDa/135kDa), or trafficking, for the 3 variants relative to WT hERG. V198E/P202L hERG has decreased trafficking efficiency (n = 4, P = 0.0002), N-Myc has increased trafficking efficiency relative to WT hERG (n = 4, P = 0.0076) and C-Myc has decreased mature/immature ratio relative to WT hERG (n = 5, P = 0.0165) 0.5% Tween-20, and 5% nonfat dry milk for 30 minutes (Santa Cruz, Dallas, TX, USA). The membrane was washed 3 times in TBS-T and stained over night at 4 • C in antibody H175 Rabbit anti-hERG (Santa Cruz) diluted 1:500 in 5% milk. Secondary stain was done with IRDye 800CW anti-Rabbit secondary antibody (Li-Cor) diluted 1:10,000 in 5% milk, stained 30 minutes at room temperature and imaged using the 800 channel of the Odyssey-FC. hERG protein signal was normalized to the total protein signal 10 obtained from the REVERT reading. Statistical analysis, including t-tests, was performed using GraphPad Prism.
Immunoblot
Statistical significance was determined at P < 0.05. 
Protein half-life determination

Prediction of protein damage due to mutation
Three different predictive software programs were used to assess the impact of the V198E/P202L mutations on the hERG channel protein.
These software programs cannot assess 2 mutations in a single prediction, so the impact of the mutations was assessed on an individual 3 mega-ohms were used to obtain the whole-cell configuration. 14 A MultiClamp 700B amplifier (Molecular Devices, LLC, Sunnyvale, CA, USA) was used and patch-clamp protocols were performed through the pCLAMP10 acquisition and analysis software (Molecular Devices).
Electrophysiology
The pipette offset potential in these solutions was zeroed just prior to seal formation. Whole-cell capacitance (generally 10 to 30 pF) was compensated electronically. Whole-cell series resistance was compensated to 85% to 90% using amplifier circuitry so that the voltage errors for currents of 2 nA were always less than 6 mV. A holding potential of -80 mV was used for patching and whole-cell configurations, and figure insets illustrate the voltage command protocol. The data filtering (8-pole Bessel) at 1.4 kHz and sampling at 5 kHz was done for both the activation and deactivation protocols. For inactivation protocols, data were filtered at 2 kHz with sampled at 10 kHz. All data were analyzed with CLAMPFIT software (Molecular Devices) and figures were created and statistics were performed using GraphPad Prism Software.
ANOVA, t-tests and Multiple t-tests were used to test significance, with a P-value < 0.05 determined as significant.
RESULTS
In silico analysis
Ensembl (ensembl.org), dbSNP (https://www.ncbi.nlm.nih.gov/snp), and ExAC (http://exac.broadinstitute.org/) databases documenting human genetic variations and disease causing mutations were queried.
It was determined that neither the V198E mutation nor the P202L mutation exists as a known human variant. These mutations resulted solely from PCR-introduced error. The predicted impact of the individual mutations varies. PolyPhen2 12 predicted that the V198E mutation is possibly damaging (0.650/1) and the P202L mutation is benign (0.016/1). SIFT 11 predicted both mutations to be tolerated (V198E = 0.38/1 and P202L = 0.13/1). KvSNP 13 predicted that neither mutation is a disease-causing mutation, with the V198E probability of causing disease at 0.124 and the P202L mutation probability of causing disease at 0.433. Although these mutations were analyzed individually, and the impact of both mutations cannot be predicted, these results suggest that mutations are tolerated in the hERG protein, with the V198E mutation having a higher likelihood of being deleterious to protein function. When investigating the impact of either the N-terminal myc-tag or the V198E/P202L double mutation, the total protein expressed as well as the mature/immature protein ratio was compared to WThERG. (Fig. 1C and 1D ). The immunoblots demonstrate that both the N-terminal myc-tag as well as the double mutation resulted in significantly increased protein expression. (P = 0.0002 for the N-terminal myc-tag and P = 0.0187 for V198E/P202L-hERG). The N-myc hERG trafficked to the surface of the cell more efficiently than the WT hERG, as demonstrated by the mature/ immature protein ratio (P = 0.0076).
N-terminal myc tag and V198E/P202L independently impact hERG protein channel expression
An inverse effect however, was observed for V198E/P202L hERG trafficking. WT hERG displays significantly more surface expression than V198E/P202L hERG (P = 0.0002).
C-terminal myc tag does not affect total protein expression, but modestly decreases hERG channel trafficking
Immunoblot analysis was used as described above to compare WT hERG to C-terminal-myc hERG. Total protein expression and the mature/immature hERG protein ratio for each of the 2 samples were determined ( Fig. 1C and 1D , respectively). There was no significant difference between the total protein expression for the 2 channels. The C-terminal-myc hERG construct demonstrated decreased trafficking, or decreased mature/immature ratio when compared to WT hERG (P = 0.0165). However, the C-terminal-myc fusion seems to have less impact on the hERG protein expression overall compared to the N-terminalmyc or inadvertent V198E/P202L variants.
Protein half-life
To investigate the potential effect of either the amino terminal myc 
N-terminal myc-tag modifies hERG channel gating
Whole cell configuration of the patch clamp was used to measure potassium currents carried by the hERG channel. To determine channel activation, the membrane was stepped to various depolarizing levels (-60 to 60 mV) for 1.5 sec, then repolarized to -40 mV for 0.5 sec and finally hyperpolarized to -120 mV for 0.5 sec. A voltage-dependent activation curve (Fig. 3C ) was generated by measuring the peak out- where I is the relative tail current amplitude, V is the applied membrane voltage, V1⁄2 is the voltage at half-maximal activation, and k is the slope factor (Fig. 3D) . The V1⁄2 is for WT hERG is -7.182 ± 0.1371 and the V1⁄2 for N-myc hERG is -17.72 ± 0.9231. This indicates that the N-terminal myc tag produced a hyperpolarizing shift in the voltage dependence of activation. Current density was determined by obtaining the peak current at the depolarization step, and was normalized to cell capacitance. There was a trend for increased current density when the N-terminal myc-tag was included in the hERG protein channel (mean current density (pA/pF) for N-Myc hERG was 214.7 ± 33.4, while WT hERG mean was 153.7 ± 29.4), which is consistent with the immunoblot data demonstrating an increased amount of N-myc hERG protein, as well as increased trafficking of N-myc hERG protein to the surface of the cell (Fig. 3B) .
The impact of the N-terminal myc tag on hERG channel deactivation was investigated. To determine deactivation, a pulse depolarizing the membrane to +20 mV for 1. 
V198E/P202L hERG does not significantly affect hERG channel function
The impact of the 2 mutations, V198E and P202L, on hERG function were investigated in the same fashion as described for N-terminal myctagged hERG. Activation and deactivation protocols were performed as described above. There were no significant differences between WT hERG and V198E/P202L hERG in current density, and the Boltzmann curves generated for the VDA were identical. (Fig. 4B and 4C ). The activation of both channels demonstrates WT I Kr . There was not a significant difference in current density, although there was a trend towards decreased current density in the V198E/P202L hERG mutation (mean current density (pA/pf) for V198E/P202L hERG was 58.58 ± 13.87, and WT hERG was 76.3 ± 13.93), confirming the description of the original mutation. 7 There were also not significant differences in deactivation between WT hERG and V198E/P202L hERG. Both channels demonstrated comparable fast and slow time constants for deactivation (Fig. 4E ). V198E/P202L hERG produces WT I Kr .
The C-terminal myc fusion tag impacts hERG channel kinetics
The impact of the C-terminal myc fusion tag on hERG function was investigated with the same methods used for N-terminal myc-tagged hERG. Differences between WT hERG and C-myc hERG were noted The major impact that the C-terminal-myc fusion tag has on the hERG channel function is in the deactivation of the channel. There are significant differences in both the slow and fast time components of deactivation ( Fig. 5F and 5G ). There are also significant differences in the amount that Fast Tau contributes to total deactivation, showing that Fast Tau in C-terminal-myc hERG plays a much larger role in deactivation when compared to WT hERG (Fig. 5E ). However, it is important to note that the changes in the deactivation characteristics between WT hERG and C-terminal-myc hERG are much less severe than the changes between WT hERG and N-myc hERG. 
N-terminal myc-tag confounds analysis of a clinical LQT2 mutation in hERG
We previously reported a clinical LQT2 variant, D219V, with rapid deactivation kinetics as the primary defect. 9 In this case, the Nterminal myc-tag construct was used and 2 inadvertent PCR variants V198E and P202L were included in the sequence. To determine if the epitope tag and variants significantly influenced our functional analysis we compared the D219V hERG variant without the N-terminal fusion myc tag and the noted V198E/P202L variant to WT untagged hERG. Protein expression and channel function were assayed as described above. Although there was no difference in mature/immature ratio between WT hERG and D219V hERG, there was a significant decrease in total protein expression of D219V
hERG when compared to WT hERG (Fig. 6) , and a trend towards decreased protein expression for the 50/50 D219V/WT hERG (WT hERG normalized to 1, 50/50 D219V/WT hERG normalized to WT was 0.845 ± 0.22).
When comparison of D219V hERG channel function to WT hERG was done with electrophysiology, only differences in current density were noted. When voltage-dependent activation was examined, D219V hERG and WT hERG data were fit with the same Boltzmann curve, indicating no differences in the voltage-dependence of D219V
and WT hERG activation (Fig. 7B) . Current density for D219V hERG was significantly lower than WT hERG, consistent with the channel expression reduction (Fig. 7C ) (P = 0.0326). Furthermore, D219V
hERG deactivation time constants were comparable to WT hERG channels ( Fig. 7E and 7F ).
DISCUSSION
Here we describe the impact of an N-terminal myc fusion tag, a Cterminal myc fusion tag and a PCR-induced double mutation not found in population sequence databases on the WT hERG channel protein.
We also characterize the consequences of the D219V mutation without the double mutation or the N-terminal myc-tag.
Myc tags are one of the first and most commonly used protein fusion tags for immuno-detection. 16 Immuno-epitope tags may be inserted will result in decreased current amplitude. 27 This finding is similar to the one described here for C-myc fusion tag causing a trend towards decreased current. The deactivation of other shortened Cterminal hERG proteins (∆236, ∆278) had faster deactivation rates but there was no difference in the deactivation rates of the shortest truncations. 27 This is less consistent with the findings of the C-terminal myc fusion hERG, but these data, taken together, indicate that the C-terminal myc fusion tag is likely blocking important contacts made by the distal C-terminal region of hERG, and impacting both protein trafficking, current density and channel deactivation.
Although there were significant changes caused by the C-terminalmyc fusion tag, the changes were less severe than the changes in hERG function and protein expression caused by the N-terminal myc fusion tag. If a tag must be added to hERG to facilitate investigation, the addition of the tag to the C-terminal end of hERG might be preferable to an N-terminal addition.
In addition to carefully monitoring any fusion protein tags that are added on to the WT hERG protein, it is also important to ensure that the hERG sequence is not altered from the accepted consensus sequence prior to experimentation. It has been documented that the 2 mutations (V198E and P202L) resulting from PCR error at the earliest characterization of hERG do not affect I Kr 7 , a finding that we confirm here. Although these 2 mutations do not have impact on the hERG channel function, and are predicted to be tolerated mutations, they do increase total protein expression and decrease protein trafficking. The most common mechanism for disease causing mutations in LQT2 are trafficking mutations, and if the constructs used to investigate newly documented mutations carry these other "benign" mutations, incorrect designation of "trafficking mutant" might be given to the new mutations.
The increase in half-life caused by either the myc tag or the inadvertent variant V198E/P202L likely attributes to the increased steady state expression levels observed for both constructs compared to the wild type channel. However, it also suggests that changes to the halflife/stability of a channel cannot be readily predicted by alterations in channel maturation caused by mutations or other environmental factors as the myc tag, which enhanced trafficking, and the double mutation which decreased trafficking, both resulted in channels with elongated half-lives. Future investigators need to ensure that they are not using hERG constructs obtained prior to 1996, and are aware of the impact that any fusion tag is having on their protein of interest.
As an example of the impact these changes can have on mutation analysis, D219V hERG was characterized again. D219V hERG was originally a mutation found from a genetic screen done in an 11-year-old male with clinically documented LQTS. He had a mild presentation of Long QT Syndrome, with only 2 episodes of syncope throughout his life.
The original analysis of the mutation indicated that it did not affect protein expression or trafficking compared to WT hERG. 9 In the present study, when both the N-terminal myc-tag was removed and the double mutants corrected, D219V hERG demonstrated a clear decrease in total protein expression. Both the N-terminal myc tag and the double mutations cause an increase in the hERG protein expression that may have corrected for the decrease in total protein expression caused by the D219V mutation. The D219V hERG protein was originally also believed to have significantly faster deactivation rates in both the slow tau and the fast tau. This was believed to be the main mechanism of disease. However, this change can now be attributed to the N-terminal myc-tag. This study demonstrated a significant decrease in current density corresponding to the decreased total expression of D219V
hERG is responsible for the LQT2 phenotype in the proband. This mutation, rather than being expressed normally and having kinetic changes that lead to disease, causes decreased protein expression, likely due to a class 1 loss of function mechanism such as increased protein degradation or reduced translation efficiency. This mutation characterization discrepancy is evidence to the importance of characterizing all unknown aspects of any plasmid being used in an experiment.
CONCLUSION
This 
